Funding accelerates deployment of biological computing systems as co-founders open flagship San Francisco lab

SAN FRANCISCO, Feb. 12, 2026 — The Biological Computing Co. (TBC), the company redefining computing for the post-silicon AI era, today launched a new class of compute that integrates living neurons with modern AI, becoming the first to deploy applied biological computing for computer vision, generative video, and AI infrastructure. The launch includes a $25 million seed round led by Primary, and coincides with the opening of TBC’s flagship lab in San Francisco’s Mission Bay to support customer deployment.

Formerly Biological Black Box (BBB), TBC connects living neurons with modern AI to make frontier models more stable, scalable, and efficient. The company’s neural-based solution integrates directly with foundation models to improve performance while reducing compute cost, reflecting a belief that the future of high-performance computing will increasingly incorporate real biology.

“While silicon has carried the field far, AI’s next breakthrough will come from alternative architectures like biological computing,” said Brian Schechter and Gaby Lorenzi of Primary Ventures. “We believe Alex, Jon and the team at TBC can deliver step-change gains for demanding workloads such as computer vision and world models, and its early progress points to a new class of AI infrastructure.”

The perfect storm driving low-power biocomputing

TBC was founded at the intersection of three global forces: breakthroughs in neuroscience, growing constraints of today’s AI systems, and an accelerating climate and energy crisis. Today’s dominant architectures rely heavily on brute-force scaling and repeated optimization cycles. These approaches have become increasingly expensive and difficult to sustain as systems move beyond static training, exposing the need for new computing paradigms that prioritize efficiency, stability, and reliability.

“The pinnacle of performant compute will closely resemble the brain in more ways than we can imagine,” said Scott Belsky, partner at A24 and previous chief of strategy at Adobe. “TBC is pursuing a north star that I believe is the most promising direction to explore the future of computing.”

From living neurons to deployable AI

TBC’s neuroscience and engineering team encodes real-world data (e.g., images, video) into living neurons, then decodes neural activity into richer representations mapped onto state-of-the-art AI models through modular adapters. In parallel, TBC’s Algorithm Discovery platform applies biologically derived principles to inform new AI system design beyond transformers, creating a compute layer that strengthens existing architectures rather than replacing them.

“Having worked at the intersection of neuroscience and AI, what excites me about TBC is that they’re not just borrowing metaphors – they’re using living neuronal cultures to discover learning rules for the next generation of AI,” noted Tim Gardner, co-founder of Neuralink.

Believing that better computers require a revolution in computing itself, TBC co-founders Alex Ksendsovsky, MD, PhD, and Jon Pomeraniec, MD, MBA, both neurosurgeon-neuroscientists, are establishing a new computing category where biological networks complement silicon to unlock new performance and efficiency capabilities across modern AI systems – demonstrating scalable quality gains that are critical for real-world products operating under tight energy constraints.

“Using the real brain for computing is paradoxically the most elusive yet the most obvious idea in the field of computer science,” says Ksendzovsky. “We’re at the ground level of paradigm shift, of what comes next, after language, after silicon,” Pomeraniec added. “We’re building infrastructure to understand and interact with the world in a fundamentally new way.”

Interested AI researchers, neuroscientists, investors, and partners can request more information at www.tbc.co.

About The Biological Computing Co.
Based in San Francisco, The Biological Computing Co. (TBC) is harnessing evolutionary intelligence to redefine computing. Our platform integrates living neurons with advanced AI, creating frontier models that are more stable, scalable, and dramatically more efficient for applications including AI processing and real-time adaptive learning. Founded by a team of neurosurgeon-scientists, biologists, and engineers with expertise in neuroscience, machine learning, computer vision, and AI, TBC is engineering the future of biocompute.

Related Links: www.tbc.co

Media Contact
The Hoffman Agency on behalf of TBC
[email protected] 

SOURCE The Biological Computing Co.

Confidential AI platform empowers enterprises to unlock and scale AI on their most sensitive data

SAN FRANCISCO, Feb. 12, 2026 — OPAQUE, the Confidential AI company defining the trust layer for enterprise AI, today announced a $24 million Series B funding round led by Walden Catalyst, with participation from returning investors including Intel Capital, Race Capital, Storm Ventures, Thomvest, and new investor and strategic partner, Advanced Technology Research Council (ATRC). This brings OPAQUE’s total funding to $55.5 million and values the company at approximately $300 million post-money.

From theory to mandate within a year, Confidential AI has been adopted and endorsed by companies like NVIDIA, AMD, Intel, Anthropic and all major hyperscalers, including Google, Microsoft Azure and AWS. According to Gartner, Confidential AI techniques are essential for enterprises securing GenAI workflows and protecting sensitive data used by AI models.

Enterprises across industries are eager to deploy AI agents on proprietary data to drive productivity and gain a competitive advantage, but most are blocked by data leakage and compliance risks. This widening “trust chasm” is causing AI initiatives to stall in pilots as CISOs, compliance, and legal teams pause deployments over concerns about privacy, policy enforcement, and auditability.

“Enterprises will continue to struggle to bring AI into production until they have verifiable guarantees that their most sensitive data and models are protected,” said Young Sohn, Founding Managing Partner at Walden Catalyst, and board member at Samsung, Arm and Cadence. “OPAQUE solves this problem and has pioneered a platform built for verifiable privacy, policy enforcement, and model integrity, capabilities that are quickly becoming non-negotiable. We’re proud to continue to support this round and OPAQUE as they enable trusted, enterprise-grade AI adoption.”

With this new funding, OPAQUE is accelerating the delivery of its Confidential AI platform — the only secure, auditable infrastructure that gives enterprises verifiable proof that their data privacy, model integrity, and policy enforcement are provable before, during, and after runtime. For organizations under pressure to innovate quickly while meeting rising compliance standards, OPAQUE offers a path to deploy AI with confidence, transparency, and verifiable trust.

“The real barrier to enterprise AI is trust,” said Aaron Fulkerson, CEO at OPAQUE. “AI won’t scale unless organizations can verify, not just assume, that their data and models are protected. Confidential AI closes the trust gap by delivering runtime proof that data stayed private during computation, model weights were never exposed, and policies were enforced exactly as written. We’re accelerating the shift to a confidential-first infrastructure so every enterprise can turn sensitive data from a liability into a competitive advantage.”

OPAQUE is expanding into post-quantum security, confidential AI training, and sovereign cloud environments, enabling enterprises to confidently scale AI across their most sensitive workloads. This investment strengthens OPAQUE’s mission to make AI governance by design the new standard for enterprise AI.

“There is no such thing as sovereign AI without verifiable guarantees on how data, models, and policies are protected and governed,” said Dr. Najwa Aaraj, CEO of the Technology Innovation Institute (TII). “OPAQUE provides the confidential and cryptographically verifiable foundation that empowers our combined technologies to operate AI systems with true sovereignty. This is why we’re excited to be both an investor and a partner, given our shared commitment to advancing Confidential AI innovation.”

This funding comes on the heels of the launch of OPAQUE Studio, a development environment that lets enterprises build and deploy Confidential AI agents with runtime-verifiable privacy, policy compliance, and auditability.

About OPAQUE
OPAQUE is the Confidential AI company. Born from UC Berkeley’s RISELab, OPAQUE solves the core challenge blocking AI adoption at scale: security concerns about data leaks or compliance violations. OPAQUE provides verifiable privacy and governance for AI so organizations can safely run models, agents, and workflows on their most sensitive data. Its Confidential AI platform delivers verifiable runtime governance backed by cryptographic proof that data, models, and agent actions remain private, governed, and compliant with approved policies throughout every AI workflow. This extends traditional data governance tools with real runtime verification, enabling teams to responsibly deploy AI using their most valuable proprietary data, and move from pilot to production 4-5X faster. Customers and partners include ServiceNow, Anthropic, Encore Capital, Accenture, and leaders across high tech, financial services, insurance, and healthcare. Learn more at opaque.co.

Media contact:
Inkhouse for OPAQUE
[email protected]

SOURCE OPAQUE

HONG KONG, Feb. 11, 2026 — Inference Research, an AI-native quantitative trading franchise architected to capitalize on the convergence of Digital Assets and Traditional Finance, today announced its launch and the anticipated closing of a $20 million Seed funding round. The round was led by Avenir Group, a pioneering investment group that originated from Mr. Li Lin’s family office and is Asia’s prominent institutional investor.

Founded by Luke Li, the former Co-founder and Head of Trading at Amber Group, Inference Research is built to operate at the frontier of global market evolution—combining sovereign AI infrastructure with institutional trading discipline to tackle key challenges in modern markets, from asset pricing to liquidity provision, as global finance is being reshaped by AI and blockchain.

Strategic Partnership with Avenir Group The investment from Avenir Group validates Inference Research’s vision and provides the resources to accelerate infrastructure development and support scaling of its proprietary AI systems. As an industry pioneer dedicated to the integration of traditional finance and digital assets, Avenir Group’s strategic support enables Inference Research to pursue long-term growth with institutional-grade resilience and scale.

“Inference Research represents a compelling step forward in quantitative finance, blending institutional-grade discipline with AI-native innovation,” said Jacob Zhong, Managing Partner, Strategic Investment & Partnerships at Avenir Group. “This approach aligns closely with our mission to bridge traditional finance and digital assets, fostering resilient infrastructure and institutional adoption. We are proud to support Luke Li and the Inference Research team through strategic investment and incubation, contributing to a more unified and efficient global financial ecosystem.”

Building the Foundation The capital will be used to scale Inference Research’s sovereign infrastructure and accelerate the recruitment of world-class talent. The firm is assembling a team of exceptional quants, engineers, and researchers who value relentless curiosity and performance with integrity.

About Inference Research Inference Research is an AI-native quantitative trading franchise architected to capitalize on the convergence of Digital Assets and Traditional Finance. Combining sovereign AI technology with institutional trading discipline, the firm operates across digital assets, traditional markets, and emerging frontiers. For more information, visit www.infr.com.

About Avenir Group

Avenir Group is a pioneering investment group, originating from Mr. Li Lin’s family office, dedicated to the strategic integration of traditional finance and digital assets, driving innovation to build a leading financial ecosystem and infrastructure. Through an integrated framework of Investment, Incubation, and Operations, the group’s investments focus on digital assets, trading and financial service platforms, PayFi infrastructure, and Real-World Assets (RWA). As Asia’s largest institutional Bitcoin ETF holder, Avenir Group leads the regional market. With proven financial expertise and industry-leading capabilities, the group establishes its role as a global hub advancing capital mobility and strategic partnerships. Learn more: www.avenirx.com.

SOURCE INFERENCE RESEARCH INC.

This new workforce and workflow intelligence platform helps enterprise leaders understand what to automate and if those automations paid off.

SAN FRANCISCO, Feb.11, 2026 — Reflow today announced the launch of its workforce and workflow intelligence platform designed to help modern enterprises understand how work happens across people and systems. The company also announced a $15M+ seed round to accelerate technology development and bring operational and AI automation intelligence to more enterprise customers.

As organizations rush to adopt AI, most leaders face a familiar constraint: they can measure outputs, but they lack visibility into the work that produces them. Decisions about automation and optimization are often driven by instinct, anecdotes, or slow, expensive consulting efforts.

Reflow was built to change that. The platform makes operational work observable, showing how work flows across systems and teams, identifying what to automate, and measuring the ROI impact of those changes.

Turning operational work into data

Reflow provides real-time visibility into how work is performed across people, systems, and processes, without time tracking, self-reported data, or complex integrations.

By turning operational work into structured data, Reflow helps organizations understand their true capacity, identify which workflows to automate, and measure AI automation ROI.

Built for operations-heavy enterprises

Reflow is designed for mid-market and enterprise organizations with large operational teams performing high-volume, repeatable, computer-based work.

These teams commonly operate in functions such as customer support, accounting, tax, legal, compliance, and where accuracy and efficiency directly impact margins.

The visibility gap holding modern operations back

Most companies can answer what their teams produce, but not how that work actually gets done.

This lack of enterprise process visibility creates real operational risk. Leaders struggle to validate capacity, enforce SOPs, identify automation opportunities, or measure whether AI and automation efforts actually worked.

In an AI-driven world, that lack of visibility becomes a blocker. Automation depends on understanding human work first.

From time tracking to workflow intelligence

Traditional time tracking and productivity tools focus on individual activity, hours logged, or self-reported tasks. While useful for basic oversight, they fail to capture how work actually moves across systems and teams.

Reflow takes a system-level approach. Instead of relying solely on measuring individuals in isolation, it observes workflows, revealing how tasks flow, where bottlenecks form, and where time is truly spent.

The platform helps organizations:

• Identify bottlenecks, inefficiencies, and SOP deviations
• Decide where automation or AI will have the highest impact
• Measure the ROI of automation efforts over time

The result is a view of operations leaders can actually act on.

Designed for workflow insight, not employee surveillance

Reflow is designed to help organizations understand systems, workflows, and capacity, not monitor individual employees.

The platform is privacy-first by design and includes enterprise-grade controls such as SOC 2 Type 2 compliance, configurable metadata collection, and flexible visibility settings. Organizations have full control and can choose aggregated or anonymized views and set clear boundaries around how data is used.

Early results from enterprise operations teams

Early customers have uncovered significant hidden capacity, reduced unnecessary headcount while increasing output, and identified high-impact areas of automation.

“Reflow helped us understand the unit economics of our work and where to optimize across workflows, productivity, and cost,” said Robert Robles, Chief of Staff at Boundless and early Reflow customer. “That clarity enabled smarter automation and more scalable operations.”

“Reflow saved us $1.2M in just two months. It showed us bottlenecks and helped us prioritize the highest-impact improvements with measurable ROI,” said Rohan Powar, Finance, Analytics and Strategy leader at Collective, another early Reflow customer.

A foundation for AI-driven operations

Automation without visibility leads to wasted spend, broken processes, and disappointing outcomes. Reflow acts as the precursor to automation, helping companies see what is actually happening and decide what to automate.

“AI can’t improve what organizations don’t understand,” said Ugur Kaner, founder of Reflow. “Reflow gives leaders a clear, shared view of how work actually happens, so automation decisions are grounded in reality, not assumptions. In an AI-driven world, that visibility becomes essential infrastructure.”

In a world where AI reshapes how work gets done, Reflow ensures that leaders understand how work actually happens.

About Reflow

Reflow is a workforce and workflow intelligence platform that helps enterprises understand how work actually happens across people and systems. By making operational work observable, Reflow enables leaders to optimize workflows, deploy automation with confidence, and measure real ROI.

SOURCE Reflow

GALWAY, Ireland and BRAINTREE, Mass., Feb. 11, 2026 — Neurent Medical, the pioneer behind NEUROMARK^®, an innovative, minimally invasive solution to treat chronic rhinitis, today announced the successful close of its oversubscribed Series C financing, raising €62.5 million ($74 million) to drive commercial expansion, broaden clinical evidence, and advance its product and indication pipeline.

The financing was led by MVM Partners, with significant participation from Sofinnova Partners, and included continued support from existing investors EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners and Enterprise Ireland.

Chronic rhinitis affects millions of people worldwide and is characterized by persistent symptoms including nasal congestion, rhinorrhea (runny nose), sneezing and postnasal drip that can significantly diminish quality of life. NEUROMARK’s proprietary Impedance Controlled Radiofrequency technology targets the overactive posterior nasal nerves (PNN) that drive these symptoms, providing clinicians with a differentiated and durable treatment option designed to address the root cause, not just manage symptoms.

“I am delighted to welcome MVM Partners and Sofinnova Partners to the Neurent Medical team, two global leaders in medtech investing,” said CEO of Neurent Medical, Brian Shields. “This Series C financing will support our commercial expansion and help bring NEUROMARK to the patients and physicians who need it most.”

Neurent Medical also welcomed Kyle Dempsey, Partner at MVM Partners, and Cedric Moreau, Partner at Sofinnova Partners, to its Board of Directors.

“Millions of patients suffer from chronic rhinitis, and posterior nasal nerve ablation represents a powerful tool to provide proven relief,” said Kyle Dempsey. “In this rapidly emerging category, Neurent has set a new standard with a best-in-class solution, powered by a proprietary impedance control system that delivers real-time feedback, giving clinicians greater treatment confidence, control, and predictability during every procedure.”

“Chronic rhinitis is a widespread and often overlooked condition affecting millions of patients with limited effective treatment options. Neurent Medical has developed a truly differentiated approach supported by a growing body of clinical evidence demonstrating meaningful and durable patient benefit,” added Cedric Moreau. We also see significant potential to expand this platform into additional indications, and we are confident in our partnership with Neurent Medical at this pivotal stage of commercial growth.”

“Our mission since inception has been to meaningfully improve patients’ lives while empowering ENT physicians with predictable, minimally invasive care,” Shields continued. “In addition to expanding patient access, this investment will also enable further evidence generation across broader populations and support the continued development of our exciting pipeline offerings.”

About NEUROMARK® and Neurent Medical
Neurent Medical is dedicated to transforming the treatment landscape for chronic inflammatory sinonasal diseases. Its flagship NEUROMARK System utilizes proprietary Impedance Controlled Radiofrequency technology to gently disrupt hyperactive posterior nasal nerves, delivering durable symptom relief from chronic rhinitis with minimal downtime and a strong safety profile.

Headquartered in Galway, Ireland, with U.S. operations in Braintree, Massachusetts, Neurent is advancing both scientific evidence and clinical adoption to establish a new standard of care in chronic rhinitis management. Learn more at www.neuromark.com.

About MVM Partners
MVM has invested in high-growth healthcare businesses since 1997. With teams in Boston, London, and the San Francisco Bay Area, MVM has a broad, global investment outlook spanning medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other sectors of healthcare. More information can be found at www.mvm.com.

About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners manages over €4 billion in assets. For more information, please visit: www.sofinnovapartners.com.

SOURCE Neurent Medical

• Google Analytics founder and FPV Ventures co-founder and managing partner, Wesley Chan, joins Integrate’s Board of Directors
• Integrate’s platform has quickly become a requirement for government launch programs with the U.S. Space Force

SEATTLE, Feb. 11, 2026 — Integrate, the developer of the world’s first ultra-secure project management platform for dynamic multi-entity execution, today announced a $17 million Series A raise led by FPV Ventures with participation from Fuse VC and Rsquared VC. Returning investors include New Vista, Hyperplane, and Riot Ventures. Building on the success of its customer agreement with the U.S. Space Force, Integrate plans to leverage the funding to accelerate the launch of new product capabilities to government customers and scale its go-to-market strategy to meet the needs of the defense tech sector.      

With the nation’s defense budget expected to exceed $1 trillion in the near term, the U.S. government is investing in efforts to protect domestic innovation, bolster its competitive advantage, and maintain national security. From the first government-funded infrastructure project to today, project management has remained a major vulnerability for teams and a constant bottleneck to efficient execution. To pave new collaboration pathways for government projects, Integrate aims to unlock secure, shared multi-entity coordination, eliminating errors, delays, and losses incurred by fragmented workflows.

The first and only collaborative project management platform deployed to the classified environment Joint Worldwide Intelligence Communications System (JWICS), Integrate enables real-time collaboration on billion-dollar, top-secret projects involving hundreds of companies and stakeholders, operating across multiple clearance levels. Developed by a U.S. Air Force veteran with tenures at three aerospace unicorns, Integrate’s AI-native platform provides an ultra-secure environment for internal and external partners to eliminate siloed workflows and accelerate the development and implementation of the world’s most complex, mission-critical technologies.

Joining Integrate’s Board of Directors is FPV Ventures co-founder and managing partner Wesley Chan. An early investor in today’s software giants, including Canva, Robinhood, and Plaid, Chan’s foresight has built a robust company portfolio that includes five decacorns and more than 20 unicorns.

“It’s clear that the market has an appetite for technologies that are additive to the massive global defense tech sector,” said Wesley Chan. “Integrate’s AI-native platform has the potential to upend the market and accelerate the speed of innovation as we know it. Within one day of meeting John and the team, we were sold on their technology, market application, and results with customers.”

Integrate’s technology has rapidly become a requirement for launch programs by the U.S. Space Force. As part of its $25 million contract with the U.S. Space Force, Integrate has already added dozens of partners in aerospace and defense. With the new round of funding, Integrate plans to bring its technology into the maritime, aviation, and automotive sectors. 

“For too long, governments have wasted billions on bespoke, custom products that ultimately fall short in advertised capabilities, security, and availability. The tides are turning on widespread government inefficiency, and commercial ‘off-the-shelf’ products are becoming the new norm,” said John Conafay, CEO and co-founder of Integrate. “There is no other project management software on the market today close to offering the same level of security, accessibility, and collaborative experience that Integrate does.”

About Integrate
Integrate is the world’s first ultra-secure platform for dynamic, multi-entity collaboration, and the project management partner of choice for complex and classified projects in government and defense tech. Integrate’s technology drives innovation and streamlines orchestration where it matters most – building and operating critical land, maritime, air, space, and cyber capabilities. Backed by world-class investors like FPV Ventures, Integrate is already working with dozens of partners and customers, including the U.S. Space Force. Learn more at www.integrate.co

Media Contact
Connie Zhang
[email protected]

SOURCE Integrate

The software-driven spectrum resilience platform transforms real-time visibility and precise geolocation of Radio Frequency Interference for defense, aerospace and mobility systems

NEW YORK, Feb. 11, 2026 — Tenna Systems, a defense technology company pioneering software-driven spectrum intelligence, today announced it has raised an oversubscribed $13.5 million seed funding round led by Costanoa, with participation from Viola Ventures, Fresh Fund, 202 Ventures and existing investors. The new funding will accelerate Tenna’s expansion in the U.S. defense market, where the company has already partnered with government agencies and prime contractors to deliver hardware-free spectrum intelligence for wireless-dependent systems at global scale.

In a world where billions of dollars in defense, navigation, electronic warfare, and autonomous assets are vulnerable to connectivity gaps and Radio Frequency Interference (RFI), such as jamming and spoofing, Tenna transforms existing sensors into a unified, real-time map of the invisible domain. By turning every aircraft, drone, satellite, ship, and mobile devices into live sensors, Tenna’s platform provides actionable threat warnings by pinpointing interference within 50 to 200 meters, providing defense, aerospace, and mobility systems with real-time mission-ready resilience, without the need for additional hardware.

“Much like AccuWeather but for electronic warfare, our software transforms the blizzard of sensor data into a real-time map of Radio Frequency (RF) domains. This gives our partners a ground truth in navigating the electromagnetic spectrum,” said Avner Bendheim, co-founder and CEO at Tenna. “Agility is everything in the evolving world of the electromagnetic spectrum. While traditional solutions demand costly infrastructure rollouts and custom sensors, we provide a hardware-free solution that is as essential as any other mission-critical tool.”

Tenna was founded by twin brothers Avner and Gabriel Bendheim. After decades leading signals intelligence (SIGINT) and electronic warfare programs, they saw that traditional, hardware-heavy systems could no longer keep pace with modern warfare’s fast-moving, wireless environment. That realization led them to design their scalable, software-based solution that leverages existing signal emitters to safeguard the world’s most critical wireless systems in today’s congested spectrum.

Tenna currently offers three products to span the full range of real-time electronic connectivity needs:

• Arena for real-time monitoring of radio frequency coverage gaps and interference.
• Tracer for accurately locating interference sources and enabling targeting mitigation.
• Halo embedded software “armor” enabling operational continuity and RF resilience.

“Tenna’s founding team brings a rare mix of operational, technical, and commercial expertise,” said Greg Sands, Founder and Managing Partner at Costanoa. “We believe Tenna is advancing a new era of spectrum intelligence to protect connectivity across all domains. It has the power to transform how defense partners secure wireless systems, ensuring readiness and resilience on a global scale.”

Tenna is actively engaged with the U.S. Army, U.S. Air Force, and other federal defense agencies to advance spectrum intelligence capabilities for wireless systems, as well as operational deployments with electronic warfare and SIGINT units in allied defense forces. As the company rapidly scales, it plans to more than double its headcount in the next 12 months.

To learn more or request a demo, visit: https://tennasys.com/ 

About Tenna Systems
Founded in 2023, Tenna Systems (formerly Tip & Cue Inc.) is a software-first spectrum intelligence company building the world’s first dynamic, unified map of the electromagnetic spectrum. Tenna was founded with a singular vision: to enable seamless wireless connectivity across all domains. Drawing on decades of experience in signals intelligence (SIGINT) and electronic warfare, Tenna’s technology is battlefield-proven, having been successfully deployed with U.S. allied forces in recent conflict zones. It has delivered critical operational advantages in some of the world’s most contested environments, demonstrating its reliability, performance, and mission-ready design for wireless-dependent systems operating worldwide.

About Costanoa
Costanoa exists to elevate founders building companies of consequence. We lead investments from formation through Series A in Applied AI, AI Infrastructure, Cybersecurity, National Security, and Fintech. With $2.3B AUM, we’re boutique by design—making fewer investments to deliver deeper expertise and operational support when it matters most: the early, defining stages of growth. For more information, please visit www.costanoa.vc.

SOURCE Tenna Systems Inc.

Helping Organizations Prioritize Risk and Drive Coordinated Remediation at Scale

SARASOTA, Fla., Feb. 11, 2026 — Nucleus Security, the leader in unified vulnerability and exposure management, today announced a $20 million Series C funding round led by Delta-v Capital. Nucleus has emerged as the system of record for assets, vulnerabilities, and exposures, and the automation engine to remediate what matters most to prevent breaches.

Nucleus is leading an industry shift away from traditional vulnerability scanning to building an exposure management orchestration platform that operationalizes context, adapts to each enterprise, and closes the gap between data and action. Nucleus integrates security and asset data from more than 200 tools, business context, and AI-driven exploit intelligence into a shared, up-to-date view of exposure to drive prioritized action and measurable risk reduction across the organization.

In the past year, Nucleus has led a major replacement cycle among enterprise customers, as organizations replace expensive, homegrown vulnerability management tools that can no longer meet their needs. Nucleus provides a proven, scalable system of record, creating a uniquely compelling growth opportunity for the company in 2026 and beyond.

“This investment reinforces what our customers already know: security teams need speed, clarity, and real outcomes, not more data. We’re helping organizations cut through the noise, prioritize the risks that matter most, and reduce exposure faster in today’s cloud and AI-driven environments,” said Steve Carter, co-founder and CEO of Nucleus Security.

“Built by practitioners, the platform has emerged as the orchestration platform organizations need to unify risk across the growing sources of exposure data across IT, cloud, application, and OT environments, without vendor lock-in. Vulnerability and exposure management is increasingly a board-level responsibility; we believe Nucleus is uniquely positioned to define the next phase of this market,” said Connor Heard, Principal at Delta-v Capital.

“We invested in Nucleus because the team understood that exposure management is about driving action,” said Ryan Kruizenga, General Partner at Arthur Ventures. “Over time, they’ve proven they can execute, building a platform that scales with modern organizations, delivers real operational rigor, and consistently turns complex risk signals into measurable outcomes. Nucleus has evolved from a strong vision into a category-defining company.”

About Nucleus Security

Nucleus Security is the enterprise leader in unified vulnerability and exposure management, enabling organizations to prioritize and mitigate vulnerabilities faster, at scale. Delivering unmatched time to value, Nucleus automatically unifies and organizes data from all your security and business tools into a single pane of glass. With powerful dynamic automations, teams can effectively automate their vulnerability management program. As a FedRAMP authorized vendor, Nucleus Security is transforming how enterprises, federal agencies and defense contractors secure their digital assets and networks.

For more information about Nucleus Security and its services, please visit: https://nucleussec.com/get-started/

Contact:
[email protected]

SOURCE Nucleus Security

NEW YORK, Feb. 11, 2026 — Take2, an AI agents platform purpose-built for healthcare recruiting, today announced it has raised a $14 million Series A led by Human Capital, with participation from Bertelsmann Healthcare Investments, Reach Capital, SemperVirens VC, and Honeystone Ventures. The funding announcement was first covered by Axios.

Healthcare hiring has reached a breaking point. One in three new jobs in the U.S. is in healthcare, turnover often exceeds 50%, and vacancy costs are among the highest of any industry. Yet many recruiting workflows remain deeply manual.

Take2 is addressing that bottleneck with autonomous AI agents designed for healthcare hiring. The company’s first agent, the AI Interviewer, conducts phone interviews with candidates 24/7, evaluates them, records calls, and syncs results directly into applicant tracking systems — all with no human-in-the-loop. Trained on healthcare-specific hiring data, the platform helps organizations assess candidates more accurately while generating predictive insights that improve hiring quality and long-term retention. 

Take2 is seeing growing adoption as healthcare organizations look for faster, more scalable ways to staff their roles. Today, the platform serves leading healthcare organizations, including some of the largest health systems in the United States.

“Healthcare systems are under enormous pressure, and hiring is one of their biggest hidden costs,” said Yaniv Shimoni and Kaushik Narasimhan, co-founders of Take2. “We’re building AI agents that actually do the work — not just assist — so recruiting teams can focus on strategic decisions instead of time-consuming manual processes.”

With this funding, Take2 will expand beyond interviews into a broader network of AI agents that automate the end-to-end recruiting process, including sourcing, screening, credential verification, scheduling, and employee onboarding. By automating more of the funnel, Take2 aims to help healthcare organizations save millions of dollars annually while improving quality of hire and employee retention.

“The bottom line is that Take2 works — it’s not just a promise,” said Joe Gage, CHRO at Mercy Health and Chairperson-Elect of the Catholic Health Association. “It enables faster recruiting and hiring, and a more economical, scalable hiring system with a better candidate experience.”

About Take2
Take2 is an AI agents platform purpose-built for healthcare recruiting. Its agent network automates the end-to-end hiring process — from job posting to job offer. Take2’s mission is to manage healthcare recruiting with autonomous AI agents, helping organizations reduce costs, hire faster, and improve retention and quality of hire.

Media Contact
David Levy
929-258-8333
[email protected] 

SOURCE Take2